# Automatic Data Processing Inc: financial statements, quarterly

ADP · Nasdaq · CIK 8670 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/adp.md) · [Financials](/companies/adp/financials.md) · [Filings](/companies/adp/filings.md) · [Insiders](/companies/adp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/adp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,512](/filings/0000008670-24-000030.md) | [4,668](/filings/0000008670-25-000007.md) | [5,254](/filings/0000008670-25-000015.md) | [4,769 d](/filings/0000008670-26-000030.md) | [4,833](/filings/0000008670-25-000047.md) | [5,048](/filings/0000008670-26-000011.md) | [5,553](/filings/0000008670-26-000022.md) | [5,127 d](/filings/0000008670-26-000030.md) | [5,175](/filings/0000008670-25-000047.md) | [5,359](/filings/0000008670-26-000011.md) | [5,939](/filings/0000008670-26-000022.md) | [5,474 d](/filings/0000008670-26-000030.md) |
| Cost of revenue | $m | [2,515](/filings/0000008670-24-000030.md) | [2,562](/filings/0000008670-25-000007.md) | [2,768](/filings/0000008670-25-000015.md) | [2,632 d](/filings/0000008670-26-000030.md) | [2,634](/filings/0000008670-25-000047.md) | [2,743](/filings/0000008670-26-000011.md) | [2,904](/filings/0000008670-26-000022.md) | [2,817 d](/filings/0000008670-26-000030.md) | [2,836](/filings/0000008670-25-000047.md) | [2,890](/filings/0000008670-26-000011.md) | [3,072](/filings/0000008670-26-000022.md) | [2,963 d](/filings/0000008670-26-000030.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [237](/filings/0000008670-24-000030.md) | [229](/filings/0000008670-25-000007.md) | [243](/filings/0000008670-25-000015.md) | [248 d](/filings/0000008670-26-000030.md) | [233](/filings/0000008670-25-000047.md) | [240](/filings/0000008670-26-000011.md) | [247](/filings/0000008670-26-000022.md) | [269 d](/filings/0000008670-26-000030.md) | [251](/filings/0000008670-25-000047.md) | [258](/filings/0000008670-26-000011.md) | [254](/filings/0000008670-26-000022.md) | [266 d](/filings/0000008670-26-000030.md) |
| Selling, general and administrative | $m | [880](/filings/0000008670-24-000030.md) | [923](/filings/0000008670-25-000007.md) | [941](/filings/0000008670-25-000015.md) | [1,035 d](/filings/0000008670-26-000030.md) | [927](/filings/0000008670-25-000047.md) | [1,006](/filings/0000008670-26-000011.md) | [1,016](/filings/0000008670-26-000022.md) | [1,103 d](/filings/0000008670-26-000030.md) | [1,006](/filings/0000008670-25-000047.md) | [1,068](/filings/0000008670-26-000011.md) | [1,082](/filings/0000008670-26-000022.md) | [1,252 d](/filings/0000008670-26-000030.md) |
| Interest expense | $m | [91.6](/filings/0000008670-24-000030.md) | [105](/filings/0000008670-25-000007.md) | [62.7](/filings/0000008670-25-000015.md) | [102 d](/filings/0000008670-26-000030.md) | [138](/filings/0000008670-25-000047.md) | [130](/filings/0000008670-26-000011.md) | [74.8](/filings/0000008670-26-000022.md) | [114 d](/filings/0000008670-26-000030.md) | [135](/filings/0000008670-25-000047.md) | [124](/filings/0000008670-26-000011.md) | [78.7](/filings/0000008670-26-000022.md) | [121 d](/filings/0000008670-26-000030.md) |
| Income tax | $m | [233](/filings/0000008670-24-000030.md) | [265](/filings/0000008670-25-000007.md) | [361](/filings/0000008670-25-000015.md) | [260 d](/filings/0000008670-26-000030.md) | [280](/filings/0000008670-25-000047.md) | [298](/filings/0000008670-26-000011.md) | [372](/filings/0000008670-26-000022.md) | [280 d](/filings/0000008670-26-000030.md) | [295](/filings/0000008670-25-000047.md) | [321](/filings/0000008670-26-000011.md) | [422](/filings/0000008670-26-000022.md) | [279 d](/filings/0000008670-26-000030.md) |
| Net income | $m | [859](/filings/0000008670-24-000030.md) | [878](/filings/0000008670-25-000007.md) | [1,185](/filings/0000008670-25-000015.md) | [829 d](/filings/0000008670-26-000030.md) | [956](/filings/0000008670-25-000047.md) | [963](/filings/0000008670-26-000011.md) | [1,250](/filings/0000008670-26-000022.md) | [911 d](/filings/0000008670-26-000030.md) | [1,013](/filings/0000008670-25-000047.md) | [1,062](/filings/0000008670-26-000011.md) | [1,360](/filings/0000008670-26-000022.md) | [979 d](/filings/0000008670-26-000030.md) |
| Diluted EPS | $ per share | [2.08](/filings/0000008670-24-000030.md) | [2.13](/filings/0000008670-25-000007.md) | [2.88](/filings/0000008670-25-000015.md) | not reported | [2.34](/filings/0000008670-25-000047.md) | [2.35](/filings/0000008670-26-000011.md) | [3.06](/filings/0000008670-26-000022.md) | not reported | [2.49](/filings/0000008670-25-000047.md) | [2.62](/filings/0000008670-26-000011.md) | [3.38](/filings/0000008670-26-000022.md) | not reported |
| Basic EPS | $ per share | [2.09](/filings/0000008670-24-000030.md) | [2.14](/filings/0000008670-25-000007.md) | [2.89](/filings/0000008670-25-000015.md) | not reported | [2.34](/filings/0000008670-25-000047.md) | [2.36](/filings/0000008670-26-000011.md) | [3.07](/filings/0000008670-26-000022.md) | not reported | [2.50](/filings/0000008670-25-000047.md) | [2.63](/filings/0000008670-26-000011.md) | [3.39](/filings/0000008670-26-000022.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.4](/filings/0000008670-24-000030.md) | [1.6](/filings/0000008670-25-000007.md) | [3.3](/filings/0000008670-25-000015.md) | [2.9](/filings/0000008670-26-000030.md) | [2.1](/filings/0000008670-25-000047.md) | [2.2](/filings/0000008670-26-000011.md) | [2.7](/filings/0000008670-26-000022.md) | [3.3](/filings/0000008670-26-000030.md) | [2.5](/filings/0000008670-25-000047.md) | [2.4](/filings/0000008670-26-000011.md) | [3.2](/filings/0000008670-26-000022.md) | [4.2](/filings/0000008670-26-000030.md) |
| Current assets | $bn | [40.5](/filings/0000008670-23-000040.md) | [48.5](/filings/0000008670-24-000007.md) | [55.6](/filings/0000008670-24-000014.md) | [45.5](/filings/0000008670-25-000037.md) | [39.9](/filings/0000008670-24-000030.md) | [54.3](/filings/0000008670-25-000007.md) | [46.5](/filings/0000008670-25-000015.md) | [43.3](/filings/0000008670-26-000030.md) | [44.2](/filings/0000008670-25-000047.md) | [74.5](/filings/0000008670-26-000011.md) | [54.2](/filings/0000008670-26-000022.md) | [52.6](/filings/0000008670-26-000030.md) |
| Total assets | $bn | [49.3](/filings/0000008670-23-000040.md) | [57.1](/filings/0000008670-24-000007.md) | [64.2](/filings/0000008670-24-000014.md) | [54.4](/filings/0000008670-26-000030.md) | [49.5](/filings/0000008670-24-000030.md) | [64.1](/filings/0000008670-25-000007.md) | [56.4](/filings/0000008670-25-000015.md) | [53.4](/filings/0000008670-26-000030.md) | [54.3](/filings/0000008670-25-000047.md) | [84.6](/filings/0000008670-26-000011.md) | [64.5](/filings/0000008670-26-000022.md) | [63.2](/filings/0000008670-26-000030.md) |
| Current liabilities | $bn | [41.2](/filings/0000008670-23-000040.md) | [48.1](/filings/0000008670-24-000007.md) | [54.9](/filings/0000008670-24-000014.md) | [45.1](/filings/0000008670-25-000037.md) | [39.4](/filings/0000008670-24-000030.md) | [54.3](/filings/0000008670-25-000007.md) | [45.8](/filings/0000008670-25-000015.md) | [41.3](/filings/0000008670-26-000030.md) | [41.9](/filings/0000008670-25-000047.md) | [72.1](/filings/0000008670-26-000011.md) | [52.0](/filings/0000008670-26-000022.md) | [50.0](/filings/0000008670-26-000030.md) |
| Total liabilities | $bn | [45.9](/filings/0000008670-23-000040.md) | [52.7](/filings/0000008670-24-000007.md) | [59.6](/filings/0000008670-24-000014.md) | [49.8](/filings/0000008670-25-000037.md) | [44.2](/filings/0000008670-24-000030.md) | [59.0](/filings/0000008670-25-000007.md) | [50.6](/filings/0000008670-25-000015.md) | [47.2](/filings/0000008670-26-000030.md) | [47.9](/filings/0000008670-25-000047.md) | [78.2](/filings/0000008670-26-000011.md) | [58.1](/filings/0000008670-26-000022.md) | [57.2](/filings/0000008670-26-000030.md) |
| Long-term debt | $bn | [3.0](/filings/0000008670-23-000040.md) | [3.0](/filings/0000008670-24-000007.md) | [3.0](/filings/0000008670-24-000014.md) | [3.0](/filings/0000008670-25-000037.md) | [3.0](/filings/0000008670-24-000030.md) | [3.0](/filings/0000008670-25-000007.md) | [3.0](/filings/0000008670-25-000015.md) | [4.0](/filings/0000008670-26-000030.md) | [4.0](/filings/0000008670-25-000047.md) | [4.0](/filings/0000008670-26-000011.md) | [4.0](/filings/0000008670-26-000022.md) | [5.0](/filings/0000008670-26-000030.md) |
| Current portion of debt | $bn | [0.0](/filings/0000008670-23-000040.md) | [0.0](/filings/0000008670-24-000007.md) | [0.0](/filings/0000008670-24-000014.md) | [0.0](/filings/0000008670-25-000037.md) | [1.0](/filings/0000008670-24-000030.md) | [1.0](/filings/0000008670-25-000007.md) | [1.0](/filings/0000008670-25-000015.md) | [0.0](/filings/0000008670-26-000030.md) | [0.0](/filings/0000008670-25-000047.md) | [0.0](/filings/0000008670-26-000011.md) | [0.0](/filings/0000008670-26-000022.md) | [0.0](/filings/0000008670-26-000030.md) |
| Short-term borrowings | $bn | [0.0](/filings/0000008670-23-000040.md) | [0.0](/filings/0000008670-24-000007.md) | [0.0](/filings/0000008670-24-000014.md) | [0.0](/filings/0000008670-25-000037.md) | [4.4](/filings/0000008670-24-000030.md) | [0.0](/filings/0000008670-25-000007.md) | [0.0](/filings/0000008670-25-000015.md) | [4.8](/filings/0000008670-26-000030.md) | [5.2](/filings/0000008670-25-000047.md) | [0.0](/filings/0000008670-26-000011.md) | [0.0](/filings/0000008670-26-000022.md) | [0.0](/filings/0000008670-26-000030.md) |
| Shareholders' equity | $bn | [3.5](/filings/0000008670-25-000007.md) | [4.3](/filings/0000008670-25-000015.md) | [4.6](/filings/0000008670-25-000015.md) | [4.5](/filings/0000008670-26-000022.md) | [5.3](/filings/0000008670-26-000011.md) | [5.1](/filings/0000008670-26-000022.md) | [5.9](/filings/0000008670-26-000022.md) | [6.2](/filings/0000008670-26-000030.md) | [6.4](/filings/0000008670-26-000011.md) | [6.4](/filings/0000008670-26-000022.md) | [6.4](/filings/0000008670-26-000022.md) | [6.0](/filings/0000008670-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [327](/filings/0000008670-24-000030.md) | [1,032 d](/filings/0000008670-25-000007.md) | [1,498 d](/filings/0000008670-25-000015.md) | [1,301 d](/filings/0000008670-26-000030.md) | [824](/filings/0000008670-25-000047.md) | [1,150 d](/filings/0000008670-26-000011.md) | [1,526 d](/filings/0000008670-26-000022.md) | [1,439 d](/filings/0000008670-26-000030.md) | [642](/filings/0000008670-25-000047.md) | [1,133 d](/filings/0000008670-26-000011.md) | [2,238 d](/filings/0000008670-26-000022.md) | [1,428 d](/filings/0000008670-26-000030.md) |
| Dividends paid | $m | [516](/filings/0000008670-24-000030.md) | [516 d](/filings/0000008670-25-000007.md) | [576 d](/filings/0000008670-25-000015.md) | [575 d](/filings/0000008670-26-000030.md) | [573](/filings/0000008670-25-000047.md) | [573 d](/filings/0000008670-26-000011.md) | [628 d](/filings/0000008670-26-000022.md) | [626 d](/filings/0000008670-26-000030.md) | [627](/filings/0000008670-25-000047.md) | [629 d](/filings/0000008670-26-000011.md) | [687 d](/filings/0000008670-26-000022.md) | [683 d](/filings/0000008670-26-000030.md) |
| Share repurchases | $m | [250](/filings/0000008670-24-000030.md) | [255 d](/filings/0000008670-25-000007.md) | [292 d](/filings/0000008670-25-000015.md) | [436 d](/filings/0000008670-26-000030.md) | [373](/filings/0000008670-25-000047.md) | [272 d](/filings/0000008670-26-000011.md) | [312 d](/filings/0000008670-26-000022.md) | [324 d](/filings/0000008670-26-000030.md) | [366](/filings/0000008670-25-000047.md) | [516 d](/filings/0000008670-26-000011.md) | [581 d](/filings/0000008670-26-000022.md) | [620 d](/filings/0000008670-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [417](/filings/0000008670-23-000040.md) | [416](/filings/0000008670-24-000007.md) | [416](/filings/0000008670-24-000014.md) | [414](/filings/0000008670-24-000030.md) | [413](/filings/0000008670-25-000007.md) | [412](/filings/0000008670-25-000015.md) | [410](/filings/0000008670-25-000047.md) | [409](/filings/0000008670-26-000011.md) | [409](/filings/0000008670-26-000022.md) | [407](/filings/0000008670-25-000047.md) | [405](/filings/0000008670-26-000011.md) | [403](/filings/0000008670-26-000022.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 397,262,737 at 2026-07-31, from the cover of the [10-K filed 2026-08-05](/filings/0000008670-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.